Your browser doesn't support javascript.
loading
Using MS induced pluripotent stem cells to investigate MS aetiology.
Fortune, Alastair J; Fletcher, Jessica L; Blackburn, Nicholas B; Young, Kaylene M.
Affiliation
  • Fortune AJ; Menzies Institute for Medical Research, University of Tasmania, Liverpool St, Hobart, Australia, 7000.
  • Fletcher JL; Menzies Institute for Medical Research, University of Tasmania, Liverpool St, Hobart, Australia, 7000.
  • Blackburn NB; Menzies Institute for Medical Research, University of Tasmania, Liverpool St, Hobart, Australia, 7000.
  • Young KM; Menzies Institute for Medical Research, University of Tasmania, Liverpool St, Hobart, Australia, 7000. Electronic address: kaylene.young@utas.edu.au.
Mult Scler Relat Disord ; 63: 103839, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35523059
ABSTRACT
Multiple sclerosis (MS) is a complex disease, and its pathophysiology impacts the function of immune and central nervous system cell types. Despite extensive investigation into the aetiology of MS, the underlying cause/s remain elusive and consequently, faithful in vitro or in vivo preclinical models of MS do not exist. Advances in human stem cell technologies have enabled the generation of induced pluripotent stem cells (iPSCs) from people with MS. This review summarises the discoveries made using iPSCs derived from people with MS and explores their current and potential application/s in MS research.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Induced Pluripotent Stem Cells / Multiple Sclerosis Type of study: Etiology_studies Limits: Humans Language: En Journal: Mult Scler Relat Disord Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Induced Pluripotent Stem Cells / Multiple Sclerosis Type of study: Etiology_studies Limits: Humans Language: En Journal: Mult Scler Relat Disord Year: 2022 Document type: Article
...